Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ. Feasibility and Safety of High Dose Proton Re-irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single Institution Retrospective Study. , Pediatric Blood Cancer: 2026
Friedes C, Berger M, Linkowski L, Hollawell C, Hubbeling H, Alexander D, Kurtz G, Lustig RA, Dorsey JF, Desai AS, Phillips RE, Brem S, Davatzikos C, Nasrallah M, O'Rourke DM, Jackson C, Amankulor NM, Alonso-Basanta M, Mohan S, Bagley SJ, Lebow ES. Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study , J Neurooncology, 177(3): 2026
Messing I, Linkowski L, Riina MD, Berger M, Baron J, Wang X, Kallan M, Hubbeling HG, Lustig RA, Dorsey JF, Kurtz G, Nagda S, Lukens JN, Flowers A, Lee JYK, Amankulor NM, Jackson C, Mohan S, Amaravadi RK, Schuchter LM, Huang AC, Mitchell TC, Alonso-Basanta M, Lebow ES. Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted Therapy , Oncologist, 31(4): 2026
Jiang C, McWilliams T, Berger M, Lebow ES, Hubbeling H, Azar E, Kolker JD, Nagda SN, Kurtz G, Zou JW, Scheuermann R, Kumar A, Alonso-Basanta M. Periventricular Radionecrosis after Conventionally Fractionated Radiation for Low Grade Meningiomas , Radiation Oncology, 20(1): 2025
Melanie Berger, Cole Friedes, Lauren Linkowski, Casey Hollawell, Harper Hubbeling, Robert Lustig, Goldie Kurtz, Jay Dorsey, Arati Desai, Richard Phillips, MacLean Nasrallah, Ali Nabavizadeh, Steven Brem, John Lee, Donald O'Rourke, Nduka Amankulor, Steven Bagley, Suyash Mohan, Michelle Alonso-Basanta, Emily Lebow Clinical and Dosimetric Predictors of Severe Radiation-Induced Lymphopenia in Patients with Newly Diagnosed IDH-Wildtype High Grade Glioma Undergoing Adjuvant Radiotherapy , American Society of Radiation Oncology (ASTRO) Annual Meeting: 2025
Ian Messing, Matthew Riina, Lauren Linkowski, Xingmei Wang, Michael Kallan, Harper G. Hubbeling, Robert A. Lustig, Jay F. Dorsey, Suneel Nagda, James Kolker, Goldie Kurtz, Nduka M. Amankulor, Christina Jackson, Iahn Cajigas, John Y.K. Lee, Angela DeMichele, Amy Clark, Payal Shah, Michelle Alonso-Basanta, Emily S. Lebow Survival and CNS Disease Control Among Patients with HER2 Low Versus HER2 High Metastatic Breast Cancer with Brain Metastases Treated with SRS , American Society of Radiation Oncology (ASTRO) Annual Meeting: 2025
Goldie A Kurtz, Anusha Kalbasi, Brett Hartl, Bridget Bieda, Uri Amit, Michelle Alonso-Basanta, Michael J LaRiviere, Christine E Hill-Kayser Life-Threatening Malignancy in Pregnancy: A Case Series of Three Patients Treated with Proton Radiotherapy with Long Term Follow-up. , Canadian Associate of Radiation Oncology, Annual Meeting 2025: 2025
Matthew Riina, Emily Lebow, Yoshiya Yamada, Jessica Wilcox, Luke Pike, Brandon Imber, Ian Messing, Robert Lustig, Harper Hubbeling, Goldie Kurtz, Michelle Alonso-Basanta, Andrew Seidman, Elena Pentsova, Helena Yu, Mark Kris, Nelson Moss, Jonathan Yang, Adrienne Boire, Yao Yu Proton Craniospinal Radiation for Leptomeningeal Disease from Patients with Metastatic Solid Tumors: A Multi-Institutional Retrospective Analysis , American Society of Radiation Oncology (ASTRO) Annual Meeting: 2025
Ian Messing, Lauren Linkowski, Xingmei Wang, Michael Kallan, Harper G. Hubbeling, Robert A. Lustig, Jay F. Dorsey, Goldie Kurtz, Suneel Nagda, Ahron Flowers, John Y.K. Lee, Nduka M. Amankulor, Christina Jackson, Suyash Mohan, J. Nicholas Lukens, Ravi K. Amaravadi, Alexander C. Haung, Tara Mitchell, Michelle Alonso-Basanta, Emily S. Lebow Outcomes of SRS and Ipilimumab/Nivolumab Among Patients with Melanoma Brain Metastases , 2025 SNO/ASCO CNS Metastases Conference: 2025
Jiang C, Kim M, Han X, Chelius M, Hoover T, Kersun L, Reilly AF, Hubbeling H, Cummings E, Kurtz G, Hill-Kayser C, Plastaras JP, LaRiviere M Outcomes of Proton Therapy to Infradiaphragmatic Sites in Pediatric Patients with Hodgkin Lymphoma , Pediatric Blood Cancer: 2024